Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients.
Yasuda
H
H
Hirai
A
A
Joko
M
M
Terada
M
M
Kawabata
T
T
Maeda
K
K
Haneda
M
M
Kashiwagi
A
A
Maeda
T
T
Kikkawa
R
R
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000473:pathology; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009412:Nerve Fibers / Q000187:drug effects / Q000473:pathology*; D012236:Rhodanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012867:Skin / Q000294:innervation; D053778:Thiazolidines
D004791:Enzyme Inhibitors; D053778:Thiazolidines; C038131:epalrestat; D012236:Rhodanine; D000449:Aldehyde Reductase